eBulletin Newsletter

NCCN Flash Updates: NCCN Templates® Updated for Esophageal and Esophagogastric Junction Cancers and NCCN Guidelines with Evidence Blocks™ Updated for Non-Small Cell Lung Cancer

NCCN has published updates to the NCCN Chemotherapy Order Templates (NCCN Templates®) for Esophageal and Esophagogastric Junction Cancers to reflect the currently published NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Esophageal and Esophagogastric Junction Cancers v2.2020.

  • Changes to the Chemotherapy Regimen, Indication, References sections have been made to the following template:
    • ESO89: Pembrolizumab

 

NCCN has published updates to the NCCN Templates® for Gastric Cancer to reflect the currently published NCCN Guidelines® for Gastric Cancer v2.2020.

  • Changes to the Chemotherapy Regimen, Indication, References sections have been made to the following template:
    • GAS89: Pembrolizumab

NCCN has published updates to the following NCCN Guidelines with NCCN Evidence Blocks™:

  • Non-Small Cell Lung Cancer, Version 6.2020, includes updates from Versions 4-6

3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462
Phone: 215-690-0300
Fax: 215-690-0280
Copyright © National Comprehensive Cancer Network, All Rights Reserved.

No portion of this Site or any NCCN Content may be copied, transferred, reproduced, modified, or otherwise used for any purpose without NCCN’s express written permission.
See Legal Notices Section for additional notices and terms governing your use of this Site.